Cargando…
Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer
The efficacy of apatinib has been confirmed in the treatment of solid tumors, including non-small-cell lung cancer (NSCLC). However, the direct functional mechanisms of tumor lethality mediated by apatinib and the precise mechanisms of drug resistance are largely unknown. In this study, we demonstra...
Autores principales: | Zhou, Xiaoshu, Zhou, Rui, Rao, Xinrui, Hong, Jiaxin, Li, Qianwen, Jie, Xiaohua, Wang, Jian, Xu, Yingzhuo, Zhu, Kuikui, Li, Zhenyu, Wu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304404/ https://www.ncbi.nlm.nih.gov/pubmed/35864117 http://dx.doi.org/10.1038/s41419-022-05079-y |
Ejemplares similares
-
NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer
por: Rao, Xinrui, et al.
Publicado: (2022) -
Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors
por: Xu, Yingzhuo, et al.
Publicado: (2022) -
Involvement of endothelial CK2 in the radiation induced perivascular resistant niche (PVRN) and the induction of radioresistance for non-small cell lung cancer (NSCLC) cells
por: Li, Qianwen, et al.
Publicado: (2019) -
PD-1(+) mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
por: Li, Jun, et al.
Publicado: (2022) -
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study
por: Li, Zhenyu, et al.
Publicado: (2023)